Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosis
The generic EQ-5D-5L performed adequately in discriminating between CF disease severity, and its index score and EQ-VAS had moderate correlations with CFQoL. However, using a complementary condition-specific measure alongside the EQ-5D-5L can provide better insight of HRQoL in CF and benefit the process of cost-utility analysis.
Authors
- Daniel Office (ORCID: https://orcid.org/0000-0001-9709-1073)
- Janice Abbott
- Rana Altabee (ORCID: https://orcid.org/0000-0001-8626-5269)
- S.B. Carr (ORCID: https://orcid.org/0000-0003-0580-2478)
- Rory Cameron (ORCID: https://orcid.org/0000-0002-7442-0935)
- Garry Barton (ORCID: https://orcid.org/0000-0001-9040-011X)
- David Turner (ORCID: https://orcid.org/0000-0002-1689-4147)
- Jennifer A. Whitty (ORCID: https://orcid.org/0000-0002-5886-1933)
- Nicholas J. Simmonds
Institutions
- University of East Anglia (GB)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- University of Lancashire (GB)
- Royal Brompton Hospital (GB)
- Lung Institute (US)
Publication Details
- Journal
- Respiratory Medicine and Research
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.resmer.2024.101137
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- King Saud bin Abdulaziz University for Health Science
- Research for Patient Benefit Programme